Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Inventory: 2022-2025

Historic Inventory for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $5.7 million.

  • Immunocore Holdings' Inventory rose 25.17% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 25.17%. This contributed to the annual value of $5.4 million for FY2024, which is 21.00% up from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Inventory is $5.7 million, which was up 3.65% from $5.5 million recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Inventory peaked at $6.8 million during Q1 2025, and registered a low of $692,000 during Q4 2022.
  • Its 3-year average for Inventory is $5.0 million, with a median of $5.0 million in 2024.
  • Data for Immunocore Holdings' Inventory shows a peak YoY soared of 550.43% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Immunocore Holdings' Inventory stood at $692,000 in 2022, then surged by 550.43% to $4.5 million in 2023, then increased by 21.00% to $5.4 million in 2024, then grew by 25.17% to $5.7 million in 2025.
  • Its last three reported values are $5.7 million in Q3 2025, $5.5 million for Q2 2025, and $6.8 million during Q1 2025.